The agreements mean the remaining claims against the Swiss maker of generic drugs in the U.S. generic antitrust litigation are those from individual plaintiffs.
Source link
Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations
Date:
More like thisRelated
Data-Center Backlash Leads to a New Land Rush in the Texas Oil Patch
Big landowners in the Permian Basin are aiming to...
Blanche confirmed as attorney general and Israel rejects Trump’s Gaza plan: Weekend Rundown
Israel will not accept the 15-point plan for Gaza...
Storm chances increase throughout the week ahead
Isolated and scattered afternoon storms have continued to build...